glp-1 macular degeneration Agonists May Lower Risk of The use of GLP-1 receptor

Whilst several observational studies and case reports have documented improvements in psoriasis severity among patients treated with GLP-1 medications, these findings require cautious interpretation

doi:10.1016/j.amjmed.2009.05.027 Magkos F, Fraterrigo G, Yoshino J, et al

Available from: Zhang Y, Liu W, Wang Q

Conclusion and Future Directions With the recent increase in GLP-1 RA use, it is essential to explore and understand the impact of these medications on the performance of gastrointestinal procedures such as EGD and colonoscopy

However, always check with a healthcare provider to avoid any potential interactions